Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 110, Issue 4, 2003, Pages 400-404

  Gratacós, Eduard ^a,b,c   Casals, Elena ^b   Gómez, Olga ^b   Llurba, Elisa ^a   Mercader, Imma ^b   Cararach, Vicenç ^b   Cabero, Lluís ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE SEVERITY; FEMALE; HUMAN; IN VITRO STUDY; LIPID OXIDATION; PARITY; PREECLAMPSIA; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 0348209616     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-0328(03)02949-5     Document Type: Article

References (25)

1. Roberts J.M., Lain K.Y. Obstetrics. Preterm birth and pre-eclampsia - bad news and good news. Lancet. 352(Suppl 4):1998;SIV22.
2. Khong T.Y., De Wolf F., Robertson W.B., Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small for gestational age infants. Br J Obstet Gynaecol. 93:1986;1049-1059.
3. Broughton Pipkin F. What is the place of genetics in the pathogenesis of preeclampsia? Biol Neonate. 76:1999;325-330.
4. Barden A.E., Beilin L.J., Ritchie J., Walters B.N., Michael C. Does a predisposition to the metabolic syndrome sensitize women to develop preeclampsia? J Hypertens. 17:1999;1307-1315.
5. He S., Silveira A., Hamsten A., Blomback M., Bremme K. Haemostatic, endothelial and lipoprotein parameters in women with a history of preeclampsia. Thromb Haemost. 81:1999;538-542.
6. Hubel C.A., Snaedal S., Ness RB et al. Dyslipoproteinemia in postmenopausal women with a history of preeclampsia. Br J Obstet Gynaecol. 107:2000;776-784.
7. Hubel C.A., Roberts J.M., Ferrell R.E. Association of preeclampsia with common coding sequence variations in the lipoprotein lipase gene. Clin Genet. 56:1999;289-296.
8. Lundman P., Eriksson M., Schenck-Gustafsson K., Karpe F., Tornvall P. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation. 96:1997;3266-3268.
9. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 141:1998;1-15.
10. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 6:1989;67-75.
11. Lunec J. Free radical activity; methods of measurement in vivo. Chang J.Y., Lewis A.J. Pharmacological Methods in the Control of Inflammation. Modern Methods in Pharmacology. 5:1989;59-91 Alan R. Liss, New York.
12. Anderson T.J., Meredith I.T., Charbonneau F et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation. 93:1996;1647-1650.
13. Zuspan FP. The hypertensive disorders of pregnancy: report of a WHO study group. Technical Report Series 758. Geneva: WHO, 1987.
14. Gratacós E., Casals E., Deulofeu R., Cararach V., Alonso P.L., Fortuny A. Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy. Am J Obstet Gynecol. 178(5):1998;1072-1076.
15. Griffin B.A. Lipoprotein atherogenicity: an overview of current mechanisms. Proc Nutr Soc. 58:1999;163-169.
16. Chait A., Brazg R.L., Tribble D.L., Krauss R.M. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med. 94:1993;350-356.
17. Vogel R.A. Cholesterol lowering and endothelial function. Am J Med. 107:1999;479-487.
18. Hubel C.A., Lyall F., Weissfeld L., Gandley R.E., Roberts J.M. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism. 47:1998;1281-1288.
19. Sattar N., Bendomir A., Berry C., Shepherd J., Greer I.A., Packard C.J. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol. 89:1997;403-408.
20. Wakatsuki A., Ikenoue N., Okatani Y., Shinohara K., Fukaya T. Lipoprotein particles in preeclampsia: susceptibility to oxidative modification. Obstet Gynecol. 96:2000;55-59.
21. Roberts J.M., Hubel C.A. Is oxidative stress the link in the two-stage model of preeclampsia? Lancet. 354:1999;788-789.
22. Gratacós E. Lipid mediated endothelial dysfunction as a common factor to preeclampsia and chronic vascular disease. Eur J Obstet Gynecol. 92:2000;63-66.
23. Austin M.A., King M.C., Vranizan K.M., Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 82:1990;495-506.
24. De Wolf F., Robertson W.B., Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol. 123:1975;164-174.
25. Broughton Pipkin F. Risk factors for preeclampsia. N Engl J Med. 344:2001;925-926.